A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age

导出原文传递

翻译打印收藏纠错

作者： Glenn, Gregory M. ^[1] ; Fries, Louis F. ^[2] ; Thomas, D. Nigel ; Smith, Gale ; Kpamegan, Eloi ; Lu, Hanxin ; Flyer, David ; Jani, Dewal ; Hickman, Somia P. ; Piedra, Pedro A.

作者单位： Novavax Inc, Gaithersburg, MD USA ^[1] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA ^[2]

关键词 anti-F IgG F or fusion protein microneutralization nanoparticle vaccine palivizumab-competitive antibody (PCA)recombinant respiratory syncytial virus (RSV)

发布时间 2017-04-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览10

The Journal of Infectious Diseases

2016年213卷3期

411-422页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age

The Journal of Infectious Diseases

相似文献

The Journal of Infectious Diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age

The Journal of Infectious Diseases

相似文献

The Journal of Infectious Diseases

相关期刊

检索历史清除